MedPath
NMPA Approval

Glycopyrronium Bromide Powder for Inhalation

国药准字HJ20180002

July 1, 2021

H20180002

Drug Information

格隆溴铵吸入粉雾剂

希润

吸入粉雾剂

50μg(以C₁₉H₂₈NO₃计)

化学药品

July 1, 2021

June 30, 2026

Company Information

Applicant Company

6343 Risch, Switzerland

Manufacturing Company

siegfried barbera, s.l

Ronda Santa Maria 158, 08210 Barbera del Valles, Barcelona, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

格隆溴铵吸入粉雾剂 - NMPA 批准文号 | MedPath